Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Rivaroxaban 20 mg vs Xarelto 20 mg in Healthy Thai Volunteers (Fed)
TCTR20201122001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by Bio-innova. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20201122001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201122001.